Virogin Company

They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
Technology: Drug Design
Industry: Drug Discovery
Headquarters: Shenzhen, Guangdong, China
Founded Date: 2015
Employees Number: Undisclosed
Funding Status: N/A

Visit Website
contact@virogin.com
Register and Claim Ownership